Most important divisions relevant to this policy

These are the most important divisions related to the policy “for increasing access to medicinal cannabis products” which Catryna Bilyk could have attended. They are weighted much more strongly than other divisions when calculating the position of Catryna Bilyk on this policy.

Division	Catryna Bilyk	Supporters vote
13th Jun 2017, 1:10 PM – Senate Regulations and Determinations - Therapeutic Goods and Other Legislation Amendment (Narcotic Drugs) Regulation 2016 - Disallow	absent	Yes
11th May 2017 – Senate Regulations and Determinations - Therapeutic Goods and Other Legislation Amendment (Narcotic Drugs) Regulation 2016 - Disallow	absent	Yes

Other divisions relevant to this policy

These are less important divisions which are related to the policy “for increasing access to medicinal cannabis products” which Catryna Bilyk could have attended.

Division	Catryna Bilyk	Supporters vote
24th Nov 2022, 11:13 AM – Senate Narcotic Drugs (Licence Charges) Amendment Bill 2022 - Second Reading - Increase accessibility	No	Yes
14th Nov 2019, 12:02 PM – Senate Committees - Community Affairs References Committee - Reference	absent	Yes
13th Jun 2017, 1:04 PM – Senate Regulations and Determinations - Therapeutic Goods and Other Legislation Amendment (Narcotic Drugs) Regulation 2016 - Vote on disallowance again	absent	Yes

How "We can't say anything concrete about how they voted on" is worked out

Catryna Bilyk has only voted once on this policy and it wasn't on a "strong" vote. So it's not possible to draw a clear conclusion about their position.

This could be because there were simply not many relevant divisions (formal votes) during the time they've been in parliament (most votes happen on "the voices", so we simply have no decent record) or they were absent for votes that could have contributed to their voting record.